SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing a surge in attention after "The Big Short" investor Michael Burry disclosed a long-term value position, adding to recent insider buying by CEO Ryan Cohen. The community is actively debating whether this, alongside the stock's historical short interest, will ignite significant upward momentum, with many anticipating a potential catalyst like a return of "Roaring Kitty."

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following a government proposal for a significantly lower-than-expected increase in 2027 Medicare Advantage rates, impacting the broader managed care sector. The community is actively debating potential market manipulation and political influence, with some perceiving this as a compelling long-term buying opportunity while others anticipate further stock weakness. This development intensifies concerns about margin pressures across the industry amidst rising healthcare costs.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing intense volatility, largely driven by a leaked JPMorgan memo concerning a massive silver short position and reports of increasing global physical demand. The community is debating whether this signals the end of long-term price manipulation and the start of a historic short squeeze to much higher levels, or if it's an overbought scenario due for a significant correction.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is experiencing a significant surge driven by renewed excitement over its early investment in AI powerhouse Anthropic, now potentially valued in the billions. This has the community buzzing, with bulls celebrating the stock's breakout and strategic AI positioning, while others view it as a short-term market reaction. The discussion highlights Zoom's evolving role and potential in an AI-enhanced communication landscape.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending following its selection by NASA as the sole private company to track the high-profile Artemis II lunar mission, leveraging its Space Data Network. The community views this as a significant validation of LUNR's capabilities, bolstering its position as a key partner for NASA and a front-runner for future substantial contracts like the highly anticipated Lunar Terrain Vehicle (LTV) award.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending lower following a policy announcement proposing a near-flat increase for Medicare Advantage rates in the upcoming year, significantly below industry expectations. This news is fueling concerns about margin compression across the managed care sector and prompting an active debate among investors. The community is weighing whether this represents an overreaction, potentially presenting a buying opportunity, or a fundamental repricing due to heightened policy risk impacting future profitability.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is actively trending following its significant acquisition of a chipmaker, aiming to become a vertically integrated leader in quantum computing. The community is sharply divided, debating potential shareholder dilution and immediate market pressure against the strategic long-term benefits of securing a domestic supply chain and accelerating its hardware roadmap. This bold move is widely viewed as a pivotal step in the ongoing global quantum computing race.

Hecla Mining Co. engages in the provision of precious and base metals. It operates through the following segments: Greens Creek, Lucky Friday, Keno Hill, Casa Berardi, and Other. The company was founded by Amasa B. Campbell, Patsy Clark, and John Finch on October 14, 1891 and is headquartered in Coeur d'Alene, ID.

Hecla Mining Co.

Hecla Mining Co

Hecla Mining is trending as its Investor Day unfolded with a controversial announcement to divest the Casa Berardi gold mine, leading to sharp debate among investors. While some view the sale as a strategic move to strengthen the balance sheet and focus on silver, a significant portion of the community expressed frustration over the timing and perceived mismanagement after the stock dipped from recent highs. This has fueled active discussion around a potential dip-buying opportunity for the silver pure-play.

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Nanobiotix - ADR

Nanobiotix is trending due to a significant global licensing and co-development agreement with a major pharmaceutical company for its lead radioenhancer candidate, NBTXR3, sparking broad discussions about its long-term potential in oncology. This strategic collaboration is amplified by recent positive clinical data in difficult-to-treat cancers, leading to community excitement about NBTXR3's innovative approach to boost radiation therapy and potentially trigger a systemic immune response against tumors.

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

PureTech Health Plc - ADR

Puretech Health

PureTech Health is trending as its innovative 'hub-and-spoke' model continues to generate significant value, highlighted by the FDA approval of KarXT and key pipeline advancements. The community is actively discussing positive Phase 2 data for LYT-100 in IPF and a substantial licensing agreement by its founded entity Vor Bio, underscoring the potential of its diverse therapeutic portfolio.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sumitomo Mitsui Trust Group Inc. Sells 773,708 Shares of Standard BioTools Inc. $LAB

Sumitomo Mitsui Trust Group Inc. cut its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 12.5% during the 3rd quarter, according to its most recent disclosure with the...

Standard BioTools (NASDAQ:LAB) Shares Gap Up - Should You Buy?

Standard BioTools (NASDAQ:LAB) Shares Gap Up - What's Next...

Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% - What's Next?

Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% - Here's What Happened...

Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% - Time to Sell?

Standard BioTools (NASDAQ:LAB) Trading Down 3.9% - Here's Why...

Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) has earned an average recommendation of "Reduce" from the five research firms that are presently covering the company, Marketbeat Ratings...

Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research

Zacks Research raised shares of Standard BioTools to a "hold" rating in a research report on Thursday...

Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 75,000 shares of the stock in a transaction on Wednesday, December 3rd. The stock was acquired...

Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 125,000 shares of the company's stock in a transaction dated Tuesday, December 2nd. The stock was...

Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 150,000 shares of the business's stock in a transaction on Thursday, December 4th. The shares...

Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 125,000 Shares

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L purchased 125,000 shares of the company's stock in a transaction that occurred on Tuesday, December 2nd...

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.

Standard BioTools Inc

No change

25 bps cut

25 bps hike

Note sure, just watching

The Fed announces its rate decision this Wednesday.

Markets are pricing in a ~99% chance of no change at this week’s Fed decision, according to prediction markets. $SPY $QQQ 

FOMC on Wednesday, what do you think the Fed will decide?

LAB
Standard BioTools Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LAB News

LABStandard BioTools Inc